Neuropacalm

What Neuropacalm does

NeuropaCalm (legal entity: Neuropathy Specialities USA, LLC) is a Nevada-based private medical device company specializing in non-invasive photobiomodulation therapy for peripheral neuropathy, with a primary focus on diabetic peripheral neuropathy. The company designs and manufactures an FDA-registered infrared and near-infrared LED device in a US facility conforming to GMP and CFR800 standards. Differentiating technical features include 180-degree wide-angle illumination for uniform tissue coverage, a pulsed LED frequency profile that progresses from 73Hz to 49,000Hz during a session, thermal management that holds LEDs at 25°C to prevent output degradation, and copper integration for higher output power (claimed at five times comparable systems with half the per-milliWatt cost). The product portfolio also includes the NeuropaCalm Care Program, a turnkey clinical protocol package bundling the device with patient education and progress monitoring, and optional third-party patient financing.

The company operates a B2B2C go-to-market in which it does not sell directly to patients. Instead, licensed medical providers — including medical doctors, chiropractors, podiatrists, pharmacists, physical therapists, convenient care clinics, and independent pharmacies — register through a verified process, agree to an NDA on wholesale pricing, and become authorized resellers. Founder Patrick Doyle has worked with more than 300 clinics nationally since 2003 and focused exclusively on peripheral neuropathy since 2008, opening a neuropathy-only clinic in 2017 that produced a 2019 study reporting 93% of patients improved by an average of 77%, with no significant difference between in-clinic and at-home cohorts. Revenue is generated through wholesale hardware sales via the registered provider channel, supplemented by optional recurring consumables and financing-driven at-home sales; pricing is opaque (quote-based, NDA-protected).

The company is privately held with no disclosed external funding, no parent company, and a small disclosed leadership team (Patrick Doyle as President/CEO, Cassie Rood as COO, plus QA, customer success, and content roles). Operations are entirely US-based with no international footprint disclosed.

Name

Neuropacalm

Legal name

Neuropathy Specialities USA, LLC

Website

https://neuropacalm.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

NeuropaCalm is a Reno, Nevada-based private medical device company that sells an FDA-registered infrared LED photobiomodulation device for peripheral neuropathy through a B2B2C channel of registered medical providers. Its target end-users are patients with diabetic peripheral neuropathy, served exclusively via authorized resellers.

Ownership category

akta.pro rank

Product category

Medical Devices - Photobiomodulation Therapy

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYHSADAKAG

Infrared Therapy (Infrared Sauna & Light Therapy)

Home & Personal Services/Fitness, Wellness & Personal Training/Spa, Sauna & Recovery Services

Keywords

• Infrared light therapy
• Peripheral neuropathy treatment
• Photobiomodulation devices
• Neuropathy care programs
• Medical light therapy

Headquarters

HQ city

Reno

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Marketing or Sales, Personnel, Supply Chain

Revenue model

1. Infrared Therapy Device Sales: NeuropaCalm sells its infrared light therapy devices exclusively through registered medical provider partners. Providers become authorized resellers through a registration process and purchase devices at wholesale pricing. The company also generates revenue through the NeuropaCalm Care Program which may include recurring consumables or supplementation components alongside the device.
2. Authorized Reseller Program: Medical providers register as authorized resellers, agreeing to non-disclosure terms on wholesale pricing. Providers may not share pricing publicly on flyers, brochures, websites, social media, blogs, or forums. Pricing is quote-based and negotiated through the provider registration and login system.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

NeuropaCalm manufactures and distributes FDA-registered infrared and near-infrared LED light therapy (photobiomodulation) devices used to treat diabetic peripheral neuropathy. The company sells its devices exclusively through a registered medical provider network as part of the NeuropaCalm Care Program, a turnkey clinical solution combining the device, clinical protocols, patient education, and provider training. The company does not sell directly to patients; medical providers (chiropractors, podiatrists, pharmacists, physical therapists, clinics) must register and be verified as authorized resellers.

Product overview

NeuropaCalm offers the NeuropaCalm Care Program, a next-generation neuropathy treatment combining an FDA-registered infrared medical device with a comprehensive care model. The core product is the NeuropaCalm device—a therapeutic infrared light system using red and near-infrared LED technology to stimulate nitric oxide release, improve circulation, and support nerve regeneration. The accompanying Care Program provides turnkey clinical protocols, patient education resources, and progress monitoring tools for healthcare providers. The company operates on a B2B model, selling exclusively to licensed medical providers (chiropractors, pharmacists, physical therapists, podiatrists) who then offer the treatment to patients. Optional financing options through third-party partners enhance patient accessibility to the program.

Differentiator

Problem solved

Functional benefit

Products and services

• NeuropaCalm Device An FDA-registered at-home infrared light therapy medical device that uses red and near-infrared LED technology applied over damaged skin to release nitric oxide from red blood cells, promoting angiogenesis, improved circulation, and nerve regeneration for diabetic peripheral neuropathy patients. The device delivers five times the power output of comparable systems at half the per milliwatt cost, featuring proprietary heat management, copper integration, and 180-degree wide-angle illumination for uniform tissue coverage.
• NeuropaCalm Care Program A comprehensive neuropathy care model combining the NeuropaCalm infrared light therapy device with turnkey clinical protocols, patient education tools, and progress monitoring. The program trains registered healthcare providers (chiropractors, pharmacists, physical therapists, podiatrists) to deliver evidence-based infrared light therapy with supporting resources for patient management and treatment tracking.

Quantifiable outcome

• 93% of patients improved by an average of 77%
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• LightStim: LightStim manufactures FDA-cleared LED light therapy devices for pain relief, wrinkles, and acne used by both consumers and professionals. It competes with NeuropaCalm in the red/NIR LED therapy category and shares the B2B2C model of selling through spas, clinics, and wellness providers.
• Avazzia: Avazzia produces FDA-cleared microcurrent electrotherapeutic devices used by clinicians for pain management and tissue healing. It is comparable to NeuropaCalm in the clinician-prescribed, drug-free, electrotherapy category for chronic pain and neuropathy-adjacent conditions.
• NeuroMetrix: NeuroMetrix develops and markets FDA-cleared wearable neurostimulation devices (e.g., Quell) for chronic pain including diabetic peripheral neuropathy. It directly competes with NeuropaCalm for the diabetic peripheral neuropathy patient and the clinician-prescribed, drug-free treatment narrative.
• Anodyne Therapy: Anodyne Therapy manufactures infrared light therapy systems specifically indicated for peripheral neuropathy and chronic pain — the same therapeutic category and patient population NeuropaCalm targets. It is the closest direct competitor in clinician-prescribed infrared neuropathy treatment.
• Vielight: Vielight develops photobiomodulation (PBM) devices using near-infrared LEDs with proprietary pulsed frequency protocols for neurological and systemic conditions. It overlaps with NeuropaCalm in NIR LED technology, pulsed frequency dosing, and at-home neurological applications.

Broad incumbents

• Joovv: Joovv is a leading consumer red/NIR light therapy panel brand with broad adoption across wellness, fitness, and home users. It competes indirectly with NeuropaCalm in the at-home infrared therapy category but distributes primarily consumer-direct rather than via registered providers.
• LiteCure: LiteCure (a LightForce brand) manufactures Class IV laser therapy devices widely used by chiropractors, physical therapists, and podiatrists for pain and inflammation. It competes with NeuropaCalm for the same clinician channel and peripheral neuropathy use case, though using lasers rather than LEDs.
• Mito Red Light: Mito Red Light manufactures red and near-infrared light therapy panels sold consumer-direct and to wellness practitioners. It overlaps with NeuropaCalm on NIR LED technology and at-home use but targets a broader wellness audience rather than neuropathy specifically.
• PlatinumLED Therapy Lights: PlatinumLED manufactures high-output red/NIR therapy panels marketed for pain, recovery, and general wellness. It competes with NeuropaCalm on hardware power claims and the at-home user segment, though without a neuropathy-specific clinical positioning.

Emerging players

• Restore Hyper Wellness: Restore Hyper Wellness is a franchised wellness clinic chain offering infrared sauna, red light therapy, cryotherapy and related recovery services. It represents an emerging channel for infrared therapy adoption that competes for both patient attention and clinic partnerships relevant to NeuropaCalm's GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/neuropacalm

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuropacalm